3.25Open3.25Pre Close0 Volume20 Open Interest15.00Strike Price0.00Turnover0.00%IV3.81%PremiumOct 18, 2024Expiry Date2.58Intrinsic Value100Multiplier-2DDays to Expiry0.67Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet